CA2286052A1 - A novel bioadhesive drug delivery system based on liquid crystals - Google Patents

A novel bioadhesive drug delivery system based on liquid crystals Download PDF

Info

Publication number
CA2286052A1
CA2286052A1 CA002286052A CA2286052A CA2286052A1 CA 2286052 A1 CA2286052 A1 CA 2286052A1 CA 002286052 A CA002286052 A CA 002286052A CA 2286052 A CA2286052 A CA 2286052A CA 2286052 A1 CA2286052 A1 CA 2286052A1
Authority
CA
Canada
Prior art keywords
composition
composition according
cubic
substance
crystalline phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002286052A
Other languages
English (en)
French (fr)
Inventor
Lise Sylvest Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandberg Development AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2286052A1 publication Critical patent/CA2286052A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002286052A 1997-04-17 1998-04-17 A novel bioadhesive drug delivery system based on liquid crystals Abandoned CA2286052A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK43597 1997-04-17
DK0435/97 1997-04-17
PCT/DK1998/000159 WO1998047487A1 (en) 1997-04-17 1998-04-17 A novel bioadhesive drug delivery system based on liquid crystals

Publications (1)

Publication Number Publication Date
CA2286052A1 true CA2286052A1 (en) 1998-10-29

Family

ID=8093507

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286052A Abandoned CA2286052A1 (en) 1997-04-17 1998-04-17 A novel bioadhesive drug delivery system based on liquid crystals

Country Status (5)

Country Link
EP (1) EP0975331A1 (de)
JP (1) JP2001524958A (de)
AU (1) AU6919598A (de)
CA (1) CA2286052A1 (de)
WO (1) WO1998047487A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
CA2378401A1 (en) * 1999-08-06 2001-02-15 Max-Delbruck-Centrum Fur Molekulare Medizin Implantable active ingredient depot
US6465002B1 (en) 2000-03-13 2002-10-15 Brown University Research Foundation Liquid crystalline polymers
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
DE10057767A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Deodorant- und Antitranspirantprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
AU2003243509B2 (en) * 2002-06-13 2009-08-20 Lyotropic Therapeutics, Inc. Reversed liquid crystalline phases with non-paraffin hydrophobes
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2007504256A (ja) * 2003-09-01 2007-03-01 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 生物活性剤の送達のための組成物及び方法
AU2005324794C1 (en) * 2003-11-07 2010-12-02 Camurus Ab Somatostatin analogue formulations
PL1845942T3 (pl) * 2005-01-14 2014-07-31 Camurus Ab Preparaty analogu GnRH
US8871712B2 (en) 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
US8920782B2 (en) * 2005-01-14 2014-12-30 Camurus Ab Topical bioadhesive formulations
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
AU2005325510B2 (en) * 2005-01-21 2009-07-02 Camurus Ab Pharmaceutical lipid compositions
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
CN101184475A (zh) * 2005-04-28 2008-05-21 独立行政法人科学技术振兴机构 经皮吸收促进剂
CN101217940B (zh) 2005-06-06 2013-03-27 卡穆鲁斯公司 Glp-1类似物制剂
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
JP5143131B2 (ja) 2006-05-30 2013-02-13 インターシア セラピューティクス，インコーポレイティド 浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
CA2683610C (en) 2007-04-23 2013-01-08 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
EP2498754B1 (de) * 2009-06-25 2018-06-06 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Reverse hexagonale mesophasen (h ii) und ihre verwendung
KR101823699B1 (ko) 2009-09-28 2018-01-30 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
SG10201606271RA (en) * 2012-01-31 2016-09-29 Santen Pharmaceutical Co Ltd Non-aqueous liquid composition
CA2874367C (en) 2012-05-25 2020-08-18 Camurus Ab Somatostatin receptor agonist formulations
KR101586791B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
JP6289075B2 (ja) * 2013-01-25 2018-03-07 ロート製薬株式会社 外用組成物
KR101601035B1 (ko) 2013-02-28 2016-03-08 주식회사 종근당 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물
US10105358B2 (en) * 2013-05-09 2018-10-23 Zeenar Enterprises Pty Ltd Niacin formulation
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016195338A2 (ko) * 2015-05-29 2016-12-08 서울대학교산학협력단 액정 나노 입자, 이의 제조방법 및 친유성 약물이 봉입된 액정 나노입자를 함유하는 약물 전달 시스템
MX2017015504A (es) 2015-06-03 2018-05-15 Intarcia Therapeutics Inc Sistemas de colocacion y remoción de implante.
AU2017268161B2 (en) 2016-05-16 2020-03-12 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
CA3129328A1 (en) * 2019-10-31 2020-08-20 Chemistryrx Pyrimidine derivative containing compositions
CN114632059A (zh) * 2020-12-15 2022-06-17 南京海辰药业股份有限公司 一种包含瑞德西韦的静脉输注液体制剂及制备方法
CN112791047A (zh) * 2021-01-15 2021-05-14 中国人民解放军总医院第三医学中心 一种白藜芦醇层状液晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
WO1997013528A1 (en) * 1995-10-12 1997-04-17 Gs Development Ab A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Also Published As

Publication number Publication date
AU6919598A (en) 1998-11-13
EP0975331A1 (de) 2000-02-02
JP2001524958A (ja) 2001-12-04
WO1998047487A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
AU702030B2 (en) A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface
CA2286052A1 (en) A novel bioadhesive drug delivery system based on liquid crystals
US6228383B1 (en) Use of fatty acid esters as bioadhesive substances
EP0752855B1 (de) Verwendung von fettsäureester als bioklebstoffe
EP2301525B1 (de) Topische Ibuprofen-Formulierung
AU2004291162B2 (en) Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
US8920782B2 (en) Topical bioadhesive formulations
RU2560677C2 (ru) Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
US9649382B2 (en) Topical bioadhesive formulations
ZA200604967B (en) Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
JPH08501089A (ja) ９−［（２−ヒドロキシエトキシ）メチルグアニン（アシクロヴィア）またはその塩もしくはエステルを含む抗ウイルス活性医薬水中油型エマルジョン
CZ2004778A3 (cs) Farmaceutická formule zahrnující cyklosporin a její použití
EP1517709A1 (de) Transdermales arzneimittelverabreichungssystem
JPH11509515A (ja) 新規な医薬処方
Kaur et al. A review on study of buccal patches: current status of formulation and evaluation methods
EP1043979B1 (de) Zusammensetzungen zur transdermalen und dermalen verabreichung von biologisch wirksamen stoffen
CN114302707A (zh) 局部阿昔洛韦制剂及其用途

Legal Events

Date Code Title Description
FZDE Discontinued